We may finally know why type 2 diabetes is associated with vascular damage

Type 2 diabetes is known to increase a patient's risk of cardiovascular complications, sometimes doing serious damage to their blood vessels. The specific cause of that blood vessel damage, however, has remained largely unknown—until now. 

According to a new analysis published in Diabetes, levels of a small molecule called microRNA-210 were considerably reduced in the red blood cells of 36 patients with type 2 diabetes. On the other hand, that molecule was found in normal levels in the red blood cells of 32 healthy patients.

The study's authors observed that this reduction in microRNA-210 was responsible for alterations in specific vascular protein levels and impaired blood vessel endothelial cell function.

Furthermore, in laboratory experiments, restoration of microRNA-210 levels in red blood cells helped prevent the development of vascular injury through specific molecular changes.

“The findings demonstrate a previously unrecognized cause of vascular injury in type 2 diabetes,” said Zhichao Zhou, researcher at the department of medicine, Solna, Karolinska Institutet, Sweden, in a press release. “We hope that the results will pave the way for new therapies that increase red blood cell microRNA-210 levels and thereby prevent vascular injury in patients with type 2 diabetes.”

Read the full study here.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."